Evaluation of Cognitive Status, Kinesiophobia, Physical Activity Level, and Functional Performance in Coronary Intensive Care
1 other identifier
observational
10
1 country
1
Brief Summary
The aim of our study is to evaluate cognitive status, kinesiophobia, physical activity level, and functional performance in coronary intensive care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 19, 2022
CompletedFirst Posted
Study publicly available on registry
September 23, 2022
CompletedStudy Start
First participant enrolled
September 23, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2022
CompletedOctober 21, 2022
October 1, 2022
1 month
September 19, 2022
October 20, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Functional Performance Assessment
Functional status score for the intensive care unit (FSS-ICU) will be used.
2 weeks
Secondary Outcomes (4)
Symptom Assessment
2 weeks
Cognitive Status Assessment
2 weeks
Physical Activity Level
2 weeks
Fear of Movement
2 weeks
Study Arms (1)
Study Group
Patients who are hospitalized in the coronary intensive care unit, who can take simple commands, and whose condition is physiologically stable.
Eligibility Criteria
Patients in coronary intensive care unit who can take simple commands and whose condition is physiologically stable
You may qualify if:
- Volunteering to participate in the research
- Being under surveillance in the coronary intensive care unit
You may not qualify if:
- Presence of neurological disease that may affect the cognitive status
- Not being clinically stable
- Not to cooperate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hacettepe University
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Naciye Vardar-Yagli, PhD
Hacettepe University
- STUDY DIRECTOR
Hikmet Yorgun, PhD
Hacettepe University
- STUDY CHAIR
Ahmet Hakan Ates, PhD
Hacettepe University
- PRINCIPAL INVESTIGATOR
Dilara Saklica, MSc
Hacettepe University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 19, 2022
First Posted
September 23, 2022
Study Start
September 23, 2022
Primary Completion
November 1, 2022
Study Completion
November 1, 2022
Last Updated
October 21, 2022
Record last verified: 2022-10